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Abstract Lactic acid bacteria (LAB) are well known for
their beneficial effects on human health in the intestine and
immune system; however, there are few studies on the
impact they can generate in oral health. The aim of this
study was to test and compare in vitro antimicrobial
activity of L. reuteri on pathogenic bacteria involved in the
formation of dental caries: S. mutans, S. gordonii, and
periodontal disease: A. naeslundii and T. forsythia. Also,
we determined the growth kinetics of each bacterium
involved in this study. Before determining the antimicro-
bial action of L. reuteri on cariogenic bacteria and peri-
odontal disease, the behavior and cell development time of
each pathogenic bacterium were studied. Once the condi-
tions for good cell growth of each of selected pathogens
were established according to their metabolic requirements,
maximum exponential growth was determined, this being
the reference point for analyzing the development or
inhibition by LAB using the Kirby Bauer method.
Chlorhexidine 0.12 % was positive control. L. reuteri was
shown to have an inhibitory effect against S. mutans, fol-
lowed by T. forsythia and S. gordonii, and a less significant
effect against A. naeslundii. Regarding the effect shown by
L. reuteri on the two major pathogens, we consider its
potential use as a possible functional food in the prevention
or treatment of oral diseases.
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Introduction
The oral cavity microbiota is an ecosystem formed nearly
by 700 different microbial species [1]. This complex sys-
tem can be altered by diverse factors, including poor
hygiene and diet, smoking, stress and systemic diseases [2].
All these perturbations favor the colonization by patho-
genic bacteria and the formation of biofilms, which are
both etiological factors of periodontal diseases. Identified
pathogenic bacteria, including Streptococcus gordonii [3],
Actinomyces naeslundii [4], and Tannerella forsythia
[5, 6], contribute differently to the onset of periodontal
diseases. For example, early colonization of S. gordonii,
one of the most abundant microorganisms in dental plaques
[7], is essential for further colonization by other bacterial
strains and biofilm formation as it produces bacterial
growth-enabling adherence substrates [8]. Other bacteria
such as A. naeslundii affect the cervical areas of the teeth
and supporting tissues [9] and have been specifically
implicated in the development of caries on root surfaces
[4]. Finally, T. forsythia, which is found at the active sites
of infection, has been associated with advanced and
recurrent periodontitis [10].
Controlling the colonization of the oral cavity by path-
ogenic bacteria is essential for the prevention of peri-
odontal diseases. Studies in that respect have been focusing
on a class of nonpathogenic microorganisms called probi-
otics [11] among which Gram-positive lactic acid bacteria
(LAB) are most promising candidates. The potential health
benefits of these LAB are multiple, from stimulating the
immune system, maintaining the intestinal microflora bal-
ance, competing with pathogens, reducing childhood
allergies to controlling hyperlipidemia and/or liver disease
[12]. For example, a mix of L. acidophilus and L. casei
enhances the effect of anticancer drug 5-fluorouracil by
increasing apoptosis of colorectal cancer cell line LS513
in vitro [13, 14].
Most interesting for the control of periodontal diseases
is LAB, with antimicrobial and anti-inflammatory proper-
ties such as L. reuteri, L. fermentum, and L. casei Shirota
[15, 16]. Of these bacteria, L. reuteri is most interesting for
the control of oral microbiota as it produces reuterin, a
wide spectrum antimicrobial agent [17]. Reuterin inhibits
growth of both Gram-positive and Gram-negative bacteria,
including oral pathogens S. mutans, Actinomyces actino-
mycetemcomitans, Prevotella intermedia, Fusobacterium
nucleatum, as well as yeasts like Candida albicans, some
fungi and protozoa [18–20].
Some studies have shown promising results on the
inhibition by L. reuteri isolated from humans and rats of
both the growth of various oral pathogens, including
T. forsythia, and biofilm formation [21]. Even more inter-
esting is that antimicrobial property of L. reuteri appearing
to be maintained when food products are used as a vector
for their delivery. C¸aglar et al. [22] reported in in vivo
studies that levels of S. mutans in saliva were positively
reduced without antagonistic effects in the presence of L.
reuteri contained in tablets at a concentration of
1 9 109 CF U/mL. Another study [23] showed that con-
sumption of yogurts containing L. reuteri at different
concentrations reduced S. mutans in the oral cavity.
In this study, we determined the in vitro antimicrobial
action of L. reuteri on pathogens associated with the for-
mation of dental caries, S. gordonii and S. mutans, and with
the development of periodontal diseases, A. naeslundii and
T. forsythia.
Materials and Methods
Kinetics was assessed prior to the Kirby Bauer method, in
particular, the determination of lag and exponential phase.
The time required for both the LAB and the odontopath-
ogenic bacteria to reach their maximum exponential
growth was fundamental to testing the inhibitory effect of
Lactobacillus reuteri ATCC55730 by the Kirby Bauer
method.
Biological Material
Four strains of pathogenic oral bacteria were selected for
this study: S. gordonii (ATCC10558), Streptococcus mu-
tans UA130 (ATCC700611), Tanarella forsythia (ATCC4
3037), and A. naeslundii (ATCC51655). Culture and
growth conditions for each bacterium were based on the
technical sheets of the American Type Culture Collection
(ATCC) (Table 1).
Table 1 Media and culture conditions for organisms used as estab-
lished by the American Type Culture Collection (ATCC)
Bacterium Pre-culture–Culture
media (agar–broth)
Atmosphere Incubation
time at
37 C (h)
Lactobacillus
reuteri
MRS–MRS Anaerobic 24–48
Streptococcus
gordonii
TS–BHI Aerobic 24
Streptococcus
mutans
BHI–BHI Aerobic 24–48
Tanerella
forsythia
NAM–PY media with
Horse serum and
NAM
Anaerobic 24–48
Actinomyces
naeslundii
CAMG medium
pH 7.5 (±0.1)
Anaerobic 24–48
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Growth Conditions
Specific pre-culture on agar in Petri dishes was performed
for the bacteria for 24–48 h at 37 C (Thermo Scientific
Incubator Lab-Line, Marietta, OH); as indicated by ATCC.
L. reuteri and two of the Gram-negative oral pathogens, T.
forsythia and A. naeslundii are anaerobes and their han-
dling requires a controlled atmosphere in an anaerobic
chamber (Plas-Labs, Lansing/MI). This atmosphere was a
mixture of H2 (20.13 %), CO2 (10.13 %), and N2
(69.74 %) gas (Praxair/Mexico). All culture media as well
as the material were pre-sterilized 15 min at 120 C (All-
American, Hillsville, USA). Broth culture were carried out
in 250-mL flasks containing 200 mL of culture medium as
appropriate for each microorganism (see Table 1) and
inoculated to an optical density (OD) of 0.2 at 600 nm.
Prior to inoculation, pre-culture was washed with normal
saline (0.9 % w/v of NaCl).
The culture medium used for L. reuteri is based on
requirements indicated by the ATCC with suitable growth
conditions. The original strain was lyophilized and frozen
at -80 C. Activation was done by inoculating Man
Rogosa and Sharpe (MRS) broth (BD-Difco, Becton–
Dickinson and Company, Pont-de-Claix/France). For sub-
sequent activations from a broth culture, 15 g/L of agar
was added (Becton–Dickinson and Company).
Tannerella forsythia was previously grown on N-acetyl
muramic acid agar [24] (Sigma-Aldrich, St. Louis/MO) that
consists of 49 g tryptone soy agar (Becton–Dickinson and
Company), and 10 mL of hemin (AppliChem GMbH,
Darmstadt/Germany) suspended in 1 L of distilled water. It
was subsequently grown in peptone-yeast (PY) comprised
(g/L) of 5-peptone (Dibico/Mexico), 5-tryptone (BioBasic-
Inc.), 10-yeast extract (Dibico), 4 mL of resazurin, 40 mL of
water or normal saline, 10 mL of hemin, 0.2 mL of vitamin
K, 0.5 L-cysteine (Sigma-Aldrich), and pH 7.0 (±0.1).
Actinomyces naeslundii also requires a specific medium,
this being CAMG composed of (g/L) 5-tryptone, 5-yeast
extract (Dibico), 5-K2HPO4, 2-glucose (Jalmek-Cientı´fica/
Mexico), and 0.5 mL polysorbate 80, pH 7.5 (±0.1). The
development of both microorganisms was carried out in a
controlled gas mixture atmosphere at 37 C for 24–48 h.
Streptococcus mutans required pre-culture in tryptone
soy agar and cultured in Brain Heart Infusion broth (both
from BD Bioxon, Becton–Dickinson and Company), while
BHI was used for S. gordonii, in both inocula (Table 1).
Incubation was performed at 37 C for both strains for 24 h
for S. gordonii and 24–48 h for S. mutans.
The morphology of the strains was confirmed by growth
on agar (Petri dish) and by microscopy using differential
staining (Gram; data not shown). An inverted fluorescence
microscope (Axio Inverter Z.1, Carl Zeiss-AG/Germany)
was used.
Growth Kinetics
To determine the doubling time and specific growth rate of
each bacteria, we used a bacterial cell suspension with a
McFarland standard 2.0 (OD600 nm = 0.2–0.5) determined
with a Genesys 10 UV Scanning Spectrophotometer
(Thermo-Scientific, Madison/WI). Three 250-mL flasks
containing 200 mL of appropriate culture medium were
inoculated (Table 1) and incubated at 37 C for 3 min for
further adaptation of cells to culture conditions. Then a first
sample was taken, which represents time zero. Develop-
ment was monitored by taking samples and measuring the
OD (600 nm) and pH (Ulltrabasic-Potentiometer, Denver-
Instruments, Arvada/CO) every 3 h during 72 h for L.
reuteri culture and every hour during 25–30 h for S.
gordonii, S. mutans, T. forsythia, and A. naeslundii. Growth
kinetics was performed in duplicate for all bacterial strains.
Doubling time (h) and specific growth rate (l = h-1)
were calculated from the exponential growth phase for
each bacterium.
Inhibitory Effect of Lactobacillus reuteri
Kirby Bauer Method
The Kirby Bauer method is performed to study the activity
of antimicrobial agents against pathogenic microorganisms
[25]; in this case, L. reuteri was the agent to show anti-
microbial activity. This method is based on the formation
of growth inhibition zones around disks made of filter
paper impregnated with the antimicrobial agent. For this
study, the Kirby Bauer method was made inside an
anaerobic chamber because anaerobic conditions are
required for L. reuteri. As previously described, the path-
ogenic bacteria are inoculated in a Petri dish that has the
appropriate bacterial agar forming a monolayer. A disk is
subsequently immersed in the culture that contains the
LAB (L. reuteri) and is placed in the Petri dish. All
pathogens selected for the study were previously activated,
and each was taken in their exponential phase according to
the results previously obtained in growth kinetics.
To determine the antimicrobial effect of L. reuteri,
Chlorhexidine-digluconate 0.12 % (CHX, Consepsis Ultr-
adent Products/Inc., South Jordan/UT), an antiseptic agent
used in dentistry as a mouthwash or mouth rinse, was used
as inhibition positive control and to establish a reference of
the effect of L. reuteri on oral pathogens and sterile dis-
tilled water as a negative control. Both controls were
handled in the same way as L. reuteri, and all the proce-
dures were performed in triplicate. Finally, the Petri dishes
containing the respective antibiograms were incubated at
37 C for 24 h to determine the presence or absence of the
halos formed around the disk.
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Evaluation of the Kirby Bauer method was performed in a
qualitative manner by formation of inhibition zones at the
periphery of the disk, both for the sample of interest and its
controls. Then a quantitative analysis is made by measuring
the diameter of the inhibition halo formed for each condition.
The result was an indicator of the efficiency of antimicrobial
agent (L. reuteri) against selected pathogenic bacteria.
Statistical Analysis
Three independent replicates of each experiment were
performed, and their results were expressed as mean
diameter ± standard deviation (SD). We used data ana-
lysis, and the significances of the inhibitory effect of L.
reuteri against CHX were evaluated with unequal variance
analysis based on the *t test and the **Mann–Whitney
(P \ 0.05) test and calculated with statistical software,
STATA-13, Serial-Nr. 1910531247
Results
Bacterial morphology and differentiation were confirmed
for each oral pathogen selected in this study by standard
stains and cultures (data not shown).
Growth Kinetics
The results presented correspond to the mean value of each
experiment.
Lactobacillus reuteri showed the typical phases of
microbial growth. The lag phase lasted 8 h with no change
in OD600 nm: 0.12 ± 0.01 (Fig. 1) and a pH of
6.45 ± 0.10; at this time, exponential growth phase begins
and lasts up to 18 h, where maximum growth occurs with
an OD of 1.77 ± 0.02 and a pH 4.10 ± 0.10. After this
time, stationary phase is established with an OD of
1.8 ± 0.10 and a pH 4.29 ± 0.13.
The Gram-positive, cariogenic bacteria are seen in
Fig. 2a. S. mutans, with only 2 h from start of culture with
a pH 7.14 ± 0.01 (Fig. 2a.1), presented exponential
growth reaching its peak in 5 h with an OD of 1.15 ± 0.05
and a pH 5.83 ± 0.0. After this time, growth remained
constant until about 17 h maintaining a pH 6.185 ± 0.13.
Streptococcus gordonii has a different behavior than S.
mutans. It has no lag phase at inoculation, and logarithmic
growth reaches its maximum peak of development at 7 h
with an OD of 1.4 ± 0.05 and a pH 4.99 ± 0.01
(Fig. 2a.1); the stationary phase is then established for a
long period of time (over 20 h).
The Gram-negative, periodontopathogenic bacteria are
seen in Fig. 2b. A. naeslundii grows slowly with an initial
pH 6.7 ± 0.04 (Fig. 2b.1), and a lag phase of about 14 h;
afterward, exponential growth starts with a duration of just
3 h, reaching its maximum OD of 0.5 and a pH
5.38 ± 0.03 at 17 h of incubation. Then the stationary
phase remains constant up to 22 h, maintaining a pH
5.34 ± 0.03. T. forsythia grew very quickly, with a very
short lag phase. The start of the logarithmic phase occurred
almost immediately, reaching its peak in 5 h with an OD of
0.87 ± 0.1 and a pH 5.47 ± 0.01 (Fig. 2b.1). Subse-
quently, the stationary phase was established at about 19 h.
Doubling Time and Specific Growth Rate
The doubling time and specific growth rate (Fig. 3) were
determined and analyzed for each microorganism prior to
assessing the antimicrobial activity of L. reuteri. Of all
bacteria, growth kinetics showed that the doubling time
was the shortest for S. mutans at 0.86 ± 0.03 h and the
longest for S. gordonii and L. reuteri at about 3 h.
Remaining bacteria A. naeslundii and T. forsythia showed
intermediate doubling times of 2 h.
In general, these values were confirmed with the deter-
mination of the specific growth rate (l), this still being very
high from S. mutans compared with other microorganisms
0.81 ± 0.03 h-1. L. reuteri and S. gordonii presented very
similar specific growth rate (slower compared with studied
bacteria), with values of l = 0.24 ± 0.01 h-1 and
l = 0.23 ± 0.04 h-1, respectively. On the other hand, A.
naeslundii has a l of 0.32 ± 0.00 h-1 and a value of
0.34 ± 0.03 h-1, from T. forsythia.
Inhibitory Effect of L. reuteri
The result of each kinetic, specifically the time required for
both the LAB and the odontopathogenic bacteria to reach their
maximum exponential growth, was utilized to determine the
inhibitory effect of L. reuteri by the Kirby Bauer method.
The inhibitory halos around the disk impregnated with
L. reuteri during their peak log-growth (16 h) were mea-
sured (mm) to determine the activity of L. reuteri against
bacteria. Results of measurement of inhibition halos ofFig. 1 Growth kinetics (triangle) and pH (white bar) of L. reuteri
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both LAB and Chlorhexidine (CHX, as a positive control)
are shown in Fig. 4. L reuteri had a growth inhibitory
activity against three of the pathogenic bacteria used,
showing different inhibition halos against each one. Thus,
the larger halos were observed against S. mutans, S.
gordonii, and T. forsythia (10.3 ± 0.81, 7.3 ± 5.68 and
8.5 ± 0.54 mm, respectively), while to A. naeslundii, the
inhibition halo was small (5.8 ± 4.53 mm). With CHX, the
halos were 13.83 ± 2.13, 12.83 ± 3.18, 15.66 ± 3.50, and
6.83 ± 5.38 mm, against S. mutans, S. gordonii, and
T. forsythia, respectively. Again, the inhibition halo of A.
naeslundii was smaller than other pathogens, thus showing
resistance to CHX, as happened with L. reuteri.
Discussion
The trend in recent years is the search for new antimicro-
bial substances that can be used as an alternative to the
existing ones and that are safe, in this respect, the LAB are
Fig. 2 Growth kinetics and pH values (represented in bar) of oral
pathogenic bacteria in dental caries (a, a.1): S. gordonii (open circle,
striped bar) and S. mutans (open square, open bar), and periodontal
disease (b, b.1): A. naeslundii (filled triangle, filled bar) and T.
forsythia (filled diamond, filled striped bar)
Fig. 3 Doubling time (histogram) and specific growth rate (filled
circle) determined for each tested bacterial strain. Data are given as
mean diameter ± standard deviation
Fig. 4 Determination of bacterial susceptibility of S. mutans and S.
gordonii (present in dental caries) and A. naeslundii and T. forsythia
(in periodontal disease), to L. reuteri (filled square) and Chlorhex-
idine (open square), as antimicrobial compounds
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very promising candidates because of its well-known
health effect. In the search for therapeutic options, L.
reuteri could be a possible biological alternative for pre-
vention or treatment of oral diseases. This study demon-
strates the sensitivity of three major oral pathogens that
cause caries or periodontal disease to the probiotic L.
reuteri. Finally, analysis of bacterial growth is of great
interest in dental and general health since it contributes to
the understanding of microbial processes and their impact
on oral health.
The first part of this study include the growth kinetics of
each of the microorganisms involved, in determining the
doubling time and specific growth rate of each bacterium,
important parameters for analysis of the inhibitory effect of
L. reuteri by the Kirby Bauer method, because it is important
that microorganisms are more active metabolically.
Regarding pathogenic bacteria, growth kinetics were
very different among them. It should be noted that some of
these bacteria are specific for damaging hard structures,
like teeth enamel, while others damage soft structures, such
as those of the oral cavity. The biggest and best protective
effect of a microorganism or aggression is caused when
they are metabolically active, a phenomenon that occurs
during maximum exponential growth. Knowledge of this
phase in the kinetics of each pathogen lets us understanding
better the time that each one needs to cause damage to soft
tissues by degrading collagen present in periodontal liga-
ment, altering pH conditions in oral cavity creating an ideal
microenvironment for A. naeslundii, T. forsythia growth.
However, in hard structures, S. mutans and S. gordonii, for
example, produce organic acids as a result of their carbo-
hydrate metabolism, causing enamel demineralization.
These data give us more information on the behavior and
growth of pathogen to implement more studies about a
biological agent, which prevents their proliferation and
maybe irreversible damage on some structures of the oral
cavity. With respect to growth, the duration of the lag
phase differed greatly between pathogenic bacteria, from a
few hours or less for T. forsythensis, S. gordonii, and S.
mutans, to 14 h for A. naeslundii (Fig. 2). The lag phase for
L. reuteri is then considered as intermediate.
There are some reports on the growth of these bacteria,
although strains and culture media may differ to a point
where growth kinetics is altered [21]. For example, L.
reuteri isolated from human feces to treat against patho-
genic gastrointestinal bacteria presented a similar slow
growth dynamics as the one reported here [26]. However, it
is possible to achieve a much shorter lag phase and higher
growth rate, as shown with L. reuteri PRO 137 strain
suspended in glycerol solution [27]. Our data are consistent
with those observed in both studies.
When S. mutans is grown in anaerobic conditions, there
is an absence of a lag phase and the exponential phase is
stable for 8 h [21]. Other authors report the behavior of the
same bacteria during biofilm formation on the surface of
female rat teeth. Two hours after inoculation of the bac-
teria, growth declined due to the presence of sucrose, and
the logarithmic growth phase occurred reaching its maxi-
mum exponential point at 6 h [28].
On the other hand, there are no reports in the literature
on the growth of cariogenic bacteria S. gordonii. Data exist
only on biofilm formation and its adhesion to tooth surfaces
with the addition of carbon sources (glucose/sucrose), in
which different stages of adaptation, prevalence, and bio-
film structure development appear [29].
About the Gram-negative periodontopathogenic bacte-
ria, particularly with A. naeslundii, no previous reports on
growth stages were found. On the other side, Kang et al.
[21] used the same T. forsythia strain as in this study;
however, the lag phase lasted 8 h with a slower rate of
growth.
With these data, we can conclude that at least two of the
cariogenic bacteria selected for the study are very different
in their growth, which would explain the ability of S.
mutans to form biofilm. Development of this biofilm
requires that other microbial sources help it establish on the
surface of teeth and cause damage. It may also contain
genetic material and metabolites that are easier to synthe-
size for division and generation of two identical daughter
cells. However, we must not forget that conditions of
culture medium and incubation are important factors for
early or slow development. Logarithmic phase of each
bacterium was considered to test the inhibitory effect of L.
reuteri because microorganisms are most active and begin
the process of division in this stage. The log phase is
generally quite rapid and puts the bacterial cells in a vul-
nerable position in the possibility to be more pathogen or
effective as the case.
Antibiograms are widely used to test inhibition of
microbial growth. Asikainen [30] used antibiograms to
evaluate the effect of L. reuteri on pathogenic bacteria
from periodontal tissue, such as A. actinomycetemcomi-
tans, P. intermedia, and F. nucleatum, obtaining favorable
results in the inhibition of these pathogens. In our study, a
significative difference between the inhibition halo formed
by L. reuteri and CHX for both S. mutans and T. forsythia
(*P = 0.004 and **P = 0.001) was observed. On the other
hand, no significant difference between the effect of LAB
and CHX against S. gordonii and A. naeslundii was found
(*P = 0.065 and **P = 0.073).
C¸aglar et al. [22] reported in vivo studies where num-
bers of S. mutans in saliva were positively reduced without
antagonistic effects in the presence of L. reuteri, adminis-
tered in the form of chewing tablets at a concentration of
1 9 109 CFU/mL. Another study by Nikawa et al. [23]
revealed that consumption of yogurt containing L. reuteri
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in different concentrations reduced S. mutans in the oral
cavity. They pointed out that L. reuteri was three times
more effective than other lactobacilli and reported a mor-
tality of 90 % for S. mutans. Other studies performed with
the same LAB applied to various pathogens in the oral
cavity (C. albicans, S. mutans, Actinomyces actinomycen-
temcomitans, P. intermedia, F. nucleatum, etc.) and/or the
gastrointestinal tract (E. coli, Salmonella, Shigella, Pro-
teus, Pseudomonas, Clostridium, S. aureus, yeast, fungi,
protozoa, viruses) as Connolly showed [17].
Similar studies about reduction of S. mutans and peri-
odontal pathogens, but with other LAB, concern different
species of Lactobacillus paracasei. L. paracasei GMNL-33
is proposed as a strategy for caries prevention and man-
agement [31]. L. paracasei DSMZ16671 was used in a
pilot study under the form of sugar-free candies, showing
that their consumption reduces up to 86.6 % (±0.1) of S.
mutans in human saliva [32]. Administration of L. para-
casei in foods, oral hygiene, or oral treatment medicine can
inhibit or reduce the number of pathogens of dental caries
(S. mutans, S. sobrinus) and periodontal diseases (P. gin-
givalis, P. intermedia), in oral cavity of the user [33].
The inhibition assays in this study were performed only
with the microorganism and not with the active substance,
(reuterin). Therefore, we may expect the possibility of an
increased antimicrobial effect against these dental plaque
bacteria with the use of the active substance alone, and this
possibility is currently on testing in our laboratory. Even
the difference in sensitivity expressed by S. mutans, S.
gordonii, and T. forsythia to the action of L. reuteri may
represent a promising and interesting biological and natural
alternative in the treatment and/or prevention of oral dis-
eases. Thus, continuous study and testing of its antimi-
crobial effect at different concentrations and recognition of
its activity spectrum represent an area for active and
ongoing research. A major target is S. gordonii, a bacteria
considered an initial colonizer in the oral cavity and
responsible for the establishment of other microorganisms
with more pathogenic potential. To date, there is little
information on the mechanism of action of L. reuteri on
other pathogenic microorganisms, but it appears that reu-
terin acts on thiol groups of proteins, causing oxidative
stress [34]. Based on our results, we suggest an extended
study of L. reuteri for a deeper knowledge on its antibac-
terial properties, to allow its proposal as a supplement in
the agri-food area, as a probiotic contributing to maintain a
good oral health and avoid caries or periodontal infections.
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